KPTI

NASDAQStock

Karyopharm Therapeutics Inc.

$7.68-0.22 (-2.78%)

52-Week Range

$3.54

$10.09

Key Stats

Market Cap

65.6M

P/E Ratio

—

Dividend Yield

—

Beta

0.20

Volume

512.3K

Avg Volume

647.3K

Performance

-11.63%

+17.73%

+26.20%

YTD

+9.87%

+17.04%

-84.87%

-95.81%

Price Chart

ETF Exposure

KPTI is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.20%	2,760	$26K	$13.0M	—
IWC	iShares Micro-Cap ETF	0.03%	39,661	$347K	$1.27B	0.60%
STSB	iShares Factors US Small Blend Style ETF	0.02%	184	$1K	$7.3M	0.35%
VXF	Vanguard Extended Market ETF	0.00%	193,821	$1.3M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	25	$221	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	894	$8K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$38	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	509,129	$3.3M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,677	$24K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	230	$2K	$1.29B	0.17%

About KPTI ETF Exposure

Karyopharm Therapeutics Inc. (KPTI) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 65.6M, KPTI is a widely held institutional stock. The stock currently trades at $7.68. Investors can gain exposure to KPTI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KPTI, sorted by portfolio weight.